Tuscany's Angiography Framework Collapses With Zero Bids and No Winner

Standfirst

ESTAR has closed its 4.08 million EUR framework for cardiac angiography systems with no award and no bids. The buyer cited a change in needs. The single lot for a floor mounted C arm monoplanar system drew no electronic tenders at all. It is a rare public signal that the terms themselves may have deterred the market.

Introduction

Cardiac angiography saves lives by showing doctors what is happening inside a patient's arteries in real time. The machines that produce those images are capital equipment with long life cycles and heavy service needs. Tuscany wanted to lock in a supply path for them through a multi year framework. It went to market and found nobody willing to bid.

The buyer is ESTAR, the regional technical and administrative support body for Tuscany's health service. Its framework for angiography systems, covering both outright purchase and operational leasing, has been closed with no winner. The single lot carried an estimated value of 4,083,675.00 EUR. The stated reason for not choosing a winner is a decision by the buyer because of a change in needs. The notice records zero tenders submitted electronically.

Why This Contract Matters

Cardiology departments cannot function without angiography. Systems like the one in this lot are used for diagnostic imaging and for interventional procedures that open blocked arteries and place stents. When a regional procurement for that equipment fails, hospital modernisation plans can slip. Patients feel that delay indirectly, through slower replacement of ageing machines and longer queues for procedures.

The contract matters because a zero bid outcome is unusual and diagnostic. Bidders will accept many things but they do not stay silent without a reason. The notice does not say what the reason was. It simply records that the buyer decided needs had changed and that no electronic tenders arrived. That combination is worth reading carefully. It suggests the market and the requirement were out of step.

Contract Timeline

The result notice was dispatched on 03/11/2026 at 08:09:30 GMT and published in the Official Journal on 04/11/2026 under OJ S issue 214/2026. The notice identifier version is recorded as 13, which indicates this is a late version in a series of notice updates for the same procedure.

The notice does not disclose when the original tender was launched, when the tender period closed or on what date the buyer took the decision to close the competition. The contracting authority has not disclosed those dates. The only dates visible are the dispatch and publication dates of the result notice. Editorial analysis: a notice version number of 13 suggests the procedure went through multiple stages or corrections before reaching this result. The notice does not explain what those earlier versions contained.

Contract Overview

The buyer is ESTAR, the Ente di Supporto Tecnico Amministrativo Regionale, a body governed by public law controlled by the regional authority and active in health. The procurement was an open procedure run under Directive 2014/24/EU. It sought framework agreements for the supply of angiography systems for the health authorities of Tuscany, covering both purchase and operational leasing.

The framework covers one lot, LOT-0001, described as a monoplanar angiography system with an isocentric C arm mounted on the floor and equipped with a dynamic flat panel detector, intended for cardiological use. The estimated value is 4,083,675.00 EUR excluding VAT. The framework would have operated without reopening of competition, meaning the appointed supplier would receive call offs directly. That supplier was never found.

Key Contract Details

Project Scope

The scope is a specific class of cardiology imaging equipment. The lot describes a monoplanar system with a single C arm. The arm is isocentric, meaning it rotates around a fixed point to keep the anatomy centred during imaging. It is mounted on the floor rather than the ceiling and fitted with a dynamic flat panel detector. The stated purpose is cardiological use.

The framework covered two commercial models at once. It was set up for both outright purchase and operational leasing. That dual structure gives health authorities flexibility. A hospital with capital budget can buy. A hospital with tighter capital and an operating budget can lease. The notice does not state how many systems were expected, how the two models would be allocated or what the delivery timetable was. The contracting authority has not disclosed those details.

Because the framework operated without reopening of competition, the chosen supplier would have become the default provider for call offs under the framework. No supplier was chosen. The scope therefore remains unfilled and the underlying equipment need remains open.

About the Contracting Authority

ESTAR is the regional technical and administrative support body for Tuscany. It is classed as a body governed by public law and controlled by a regional authority, with health as its activity. Its registered office is in Firenze, postcode 50135, in the Firenze NUTS region. Its registration number is 06485540485 and its contact point is named as Francesca Martini.

ESTAR's role is to run procurement on behalf of Tuscany's health authorities. That makes it a central purchasing style body for the regional health service. When it runs a framework, it is buying on behalf of multiple local health units. Readers who want to compare how regional health procurement bodies are structured across Europe can explore the contracting authority directory.

About the Organisations Involved

ESTAR - Ente di Supporto Tecnico Amministrativo Regionale

The buyer and the only contracting party. Based in Firenze, it procures medical equipment on behalf of Tuscany's health authorities. It owns the requirement and will decide how to proceed after the closure. The notice does not say whether it will relaunch.

TAR Toscana

The review organisation. It is the regional administrative court for Tuscany, based in Firenze, postcode 50122, with registration number 80045610484. It is the forum for any challenge. The notice refers review deadlines to the tender specifications rather than stating a figure.

ANAC - Autorità Nazionale Anticorruzione

Listed as the procurement service provider. It is Italy's national anti corruption authority, based in Roma, postcode 00187, with registration number 97584460584. Its role here reflects its oversight function in Italian public procurement. The notice does not explain the specific service it provided for this procedure.

No winners, tenderers or subcontractors appear in this notice. There are none to profile. That absence is the central fact of the document.

Procurement Analysis

An open procedure is the standard route for a framework of this value under Directive 2014/24/EU. It maximises transparency and invites any qualified supplier. Choosing it for a cardiology imaging framework was logical. The framework was set up without reopening of competition, which means the buyer intended to appoint a supplier and then call off directly. That model works when the market is willing to accept a framework on the buyer's terms.

The award criteria show what the buyer valued. It used the most economically advantageous tender approach, with 30 points on price and 70 on technical quality. That is a strongly quality weighted structure, typical of medical imaging procurement where clinical performance, image quality, dose management and service support matter more than the lowest price. Bidders for angiography systems would have expected to compete hard on technical merit.

That is what makes the zero bid result striking. A quality weighted framework with a four million EUR estimate and a clear clinical requirement ought to attract interest from the major angiography vendors. It did not. The notice does not say why. It records that the reason for no award is a buyer decision because of a change in needs, and that zero electronic tenders were received.

Those two facts can be read in sequence. A change in needs may have emerged before or during the tender, and the buyer may have decided to close the procedure rather than evaluate bids. But the notice also records zero tenders received. That suggests no bids arrived at all, not that bids arrived and were set aside. The notice does not reconcile these two points. Editorial analysis: the most cautious reading is that the buyer formed the view that its requirement had changed and that the market had not engaged. The notice does not establish a causal link between the two.

The value is straightforward. The estimated value of 4,083,675.00 EUR is the buyer's estimate, not a ceiling and not a guaranteed payment. Because no contract was awarded, there is no awarded value to compare. The gap is absolute: full estimate against zero. That is the correct way to read this notice.

Two further data points matter. The procurement is not covered by the Government Procurement Agreement, so GPA member country suppliers were not automatically entitled to compete. And it is not EU funded, so there was no EU co financing driving cross border interest. Both facts narrow the potential bidder pool to domestic or voluntarily interested suppliers. Editorial analysis: that may partly explain thin interest, though the notice does not say so.

The CPV code, 33000000 for medical equipment, pharmaceuticals and personal care products, is very broad. It does not by itself signal angiography to a supplier scanning by code. A specific code for imaging equipment would have been more visible. The notice does not discuss code selection. This is editorial observation, not a stated cause of the no bid outcome.

Additional Procurement Facts

The notice does not disclose the framework duration, the number of expected systems or the allocation between purchase and leasing. These are material gaps for anyone assessing the commercial opportunity. The contracting authority has not disclosed this information.

The review deadline is not stated as a number. It refers the reader to the tender specifications. Any interested party would need the original documents to confirm the challenge window. The review body is the TAR Toscana. The notice does not state whether a standstill period applied or whether any challenge was filed.

The notice version is recorded as 13. That is a high number for a single result notice. It indicates that the procedure generated multiple notice versions, likely across the tender, clarification and result stages. The notice does not explain what changed between versions. Anyone studying the full history would need the earlier notices.

Market and Industry Perspective

Angiography systems are sold by a small group of global medical technology firms. The market is consolidated, capital intensive and service heavy. Buyers like ESTAR run frameworks to standardise equipment across hospitals and to gain volume leverage. Suppliers weigh framework participation against the terms, the call off uncertainty and the cost of bidding.

A quality weighted framework with a four million EUR estimate would normally draw interest. A zero bid outcome suggests something in the structure or timing did not work for the market. It could be the dual purchase and leasing model, the specific equipment configuration, the call off mechanism without reopening, or a change in the buyer's requirement that became apparent to suppliers before the deadline. The notice does not identify which.

The wider context is that European health systems are under pressure to replace ageing imaging equipment while managing budgets. Frameworks are the preferred vehicle. When a regional framework fails, the health authorities it serves may need to procure individually or wait for a relaunch. That fragmentation raises costs and slows replacement. Readers tracking how medical equipment frameworks are structured across Europe can review sector coverage for context.

Economic Significance

The direct economic effect is that a 4.08 million EUR equipment framework produced no contract. For the medical technology sector, that is a lost opportunity in one region. For Tuscany's health service, it is a delay in a planned equipment route. For patients, it is an indirect risk of slower access to modern angiography capacity.

The wider significance is in what the failed framework reveals about the regional equipment pipeline. ESTAR was trying to create a standing supply route for cardiology imaging. Its failure means the underlying demand is still there but the procurement vehicle did not work. That demand will need to be met somehow, either through a relaunch or through individual hospital procurements. Either route creates future market activity.

For suppliers, the economic signal is that framework terms and timing matter as much as price. A technically attractive requirement can still fail if the commercial model does not fit the market. That is a lesson with value beyond this one contract.

Future Procurement Opportunities

The most likely future opportunity is a relaunch of the angiography framework. The clinical need for cardiology imaging has not disappeared. Tuscany's health authorities still need to replace or expand angiography capacity. The buyer cited a change in needs, which suggests a revised requirement may be prepared. The notice does not confirm a relaunch or give a date. Editorial projection: a new tender is the logical next step, potentially with a revised scope, commercial model or award criteria.

A second opportunity lies in individual hospital procurements. If the regional framework does not proceed, individual health authorities may buy angiography systems directly. That would fragment the opportunity into smaller contracts. The notice does not disclose any such plans.

A third possibility is a change in the commercial model. The failed framework combined purchase and operational leasing. A relaunch might separate those into different lots or change the call off mechanics. The notice does not say. Suppliers can monitor the buyer's future publications through live European tender notices.

Opportunities for Suppliers

For angiography system vendors, this closure is a live signal that ESTAR has an unmet requirement. A buyer that has just closed a framework is a buyer that will need a new route to market. Suppliers should monitor the buyer closely and prepare for a relaunch.

The practical steps are clear. Review the original tender documents in the document library if they remain available, to understand the specification, the purchase and leasing split and the call off mechanics. Assess whether the terms were workable for your business and what changes would make a bid viable. Consider engaging with the buyer through the contact point named in the notice to understand the revised need, if the buyer is willing to discuss it.

Suppliers should also watch for individual hospital tenders that may follow. A regional framework failure often pushes procurement down to local level. Setting alerts through registration helps capture those smaller opportunities. The quality weighted criteria, 70 points on technical merit, suggest that vendors with strong clinical performance evidence and service capability will be best placed when the requirement returns.

What Businesses Should Watch

Watch for a new ESTAR notice covering angiography systems, with a revised scope or commercial model. Watch for individual Tuscan health authority tenders for cardiology imaging, which may appear if the regional route stays closed. Watch for any change in the framework mechanics, such as splitting purchase and leasing or allowing reopening of competition.

Watch the review environment too. The notice refers review deadlines to the tender specifications rather than stating a figure. Any challenge would go to the TAR Toscana. Businesses tracking Italian health procurement should monitor the buyer's publications and the relevant CPV codes. The keyword search tool can help track themes such as angiography, cardiology imaging or ESTAR frameworks.

Italy tenders.com Procurement Intelligence

The broader trend this notice represents is the fragility of regional equipment frameworks in a consolidated medical technology market. Buyers want scale and standardisation. Suppliers want workable terms and predictable volumes. When the two do not align, a framework can fail even with a strong clinical requirement and a quality weighted evaluation. ESTAR's zero bid outcome is a clear example.

The strategic importance of the award, or rather the non award, lies in what it reveals about buyer and market alignment. A 70 point technical weighting tells suppliers the buyer cares about clinical performance. A four million EUR estimate tells them the volume is meaningful. Yet no bids arrived. That gap is the intelligence signal. It suggests that factors outside the published criteria, such as the purchase and leasing structure, the call off mechanism or the timing, may have outweighed the apparent attractiveness of the contract.

For positioning, suppliers should treat failed frameworks as scheduled future opportunities. A buyer that has closed a procedure has an unmet need and a reason to re engage. Firms that understand why the first attempt failed and can propose workable terms will be better placed on the second attempt. Future contracts in this space are likely to be either a revised regional framework or a series of local hospital tenders. Suppliers should prepare for both, with strong technical evidence and a clear view of the commercial model they can support.

Supplier Takeaways

• Zero tenders were received and the buyer cited a change in needs. The notice does not explain the cause.
• The estimated value was 4,083,675.00 EUR. No contract was awarded and no ceiling is disclosed.
• Award criteria weighted technical quality at 70 points and price at 30 points.
• The framework was to run without reopening of competition and covered both purchase and operational leasing.
• A relaunch or local hospital procurements are the likely next opportunities. The notice does not confirm either.

Key Takeaways

• ESTAR closed its angiography framework with no winner and no bids.
• The single lot covered a floor mounted isocentric C arm monoplanar system with a flat panel detector for cardiology.
• The procurement was open, not GPA covered and not EU funded, under Directive 2014/24/EU.
• The notice version is 13, indicating a long procedure history that the notice does not explain.
• The clinical need for cardiology imaging remains unmet by this framework.

Conclusion

A framework that attracts no bids is a rare and revealing document. ESTAR set out to create a standing supply route for cardiology angiography systems across Tuscany. It weighted technical quality heavily, set a meaningful estimate and chose an open procedure. The market stayed away. The buyer then closed the competition citing a change in needs.

The clinical requirement has not gone away. Tuscany's hospitals still need angiography capacity, and the equipment they rely on still needs replacing. The next move belongs to the buyer, whether that is a relaunch with revised terms or a shift to local procurement. Suppliers should watch closely and prepare. The full picture of how European public procurement works, including framework mechanics and no award outcomes, is available through public procurement guidance. Readers who want to discuss the implications for their own bidding strategy can use the contact page.

Source: Tenders Electronic Daily (TED), Contract Award Notice 766994 2026, Official Journal of the European Union, OJ S issue 214/2026, published on 04/11/2026.